72 related articles for article (PubMed ID: 25066297)
1. Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells.
Gong Y; He H; Liu H; Zhang C; Zhao W; Shao RG
FEBS Lett; 2014 Aug; 588(17):2903-10. PubMed ID: 25066297
[TBL] [Abstract][Full Text] [Related]
2. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase D1 stimulates proliferation and enhances tumorigenesis of MCF-7 human breast cancer cells through a MEK/ERK-dependent signaling pathway.
Karam M; Legay C; Auclair C; Ricort JM
Exp Cell Res; 2012 Mar; 318(5):558-69. PubMed ID: 22245102
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
6. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
8. CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.
Lin HY; Sun SM; Lu XF; Chen PY; Chen CF; Liang WQ; Peng CY
Int Immunopharmacol; 2017 Oct; 51():124-130. PubMed ID: 28830025
[TBL] [Abstract][Full Text] [Related]
9. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.
Lian WJ; Liu G; Liu YJ; Zhao ZW; Yi T; Zhou HY
Oncol Rep; 2013 Jul; 30(1):193-200. PubMed ID: 23674072
[TBL] [Abstract][Full Text] [Related]
11. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
15. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
16. [Expression and activation of MAPK pathway signaling molecules in human breast cancer cell lines].
Yao Q; Luo JR; Chen JH; Zhang JL; Yuan SF; Ling R; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):328-30. PubMed ID: 15193230
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
18. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.
Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA
Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331
[TBL] [Abstract][Full Text] [Related]
19. The proliferative role of insulin and the mechanism underlying this action in human breast cancer cell line MCF-7.
Chen H; Zhang ZW; Guo Y; Wang Y; Liu Y; Luo N; Zhu Y
J BUON; 2012; 17(4):658-62. PubMed ID: 23335521
[TBL] [Abstract][Full Text] [Related]
20. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Phytomedicine; 2009 Jun; 16(6-7):573-80. PubMed ID: 19181503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
